Clinical Trial Update: Avonex-evaluation of Quality of Life and Convenience in Belgian Participants - The AVAIL Study

View source ↗

Summary

A completed clinical trial assessing quality of life and convenience of Avonex in Belgian participants with Multiple Sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Avonex (Interferon beta-1a)

Snippet

Sponsor: Biogen | Conditions: Multiple Sclerosis | Status: COMPLETED